According to www.iAsk.Ai - Ask AI:

Anticholinergic medications are drugs that block the action of acetylcholine, a neurotransmitter involved in learning and memory in the brain and muscle contractions in the body.[1] These medications are used to treat various conditions, including overactive bladder, allergies, and Parkinson's disease.[1] However, they have been linked to an increased risk of dementia, especially with long-term use in older adults.[1]

The link between anticholinergic drugs and dementia has been highlighted in several studies. A report published in JAMA Internal Medicine found a connection between long-term use of anticholinergic medications like Benadryl and an increased risk of dementia.[1] This study tracked nearly 3,500 individuals aged 65 and older and found that those who used anticholinergic drugs were more likely to develop dementia.[1] The risk increased with the cumulative dose; taking an anticholinergic for the equivalent of three years or more was associated with a 54% higher dementia risk.[1] Another study in BMC Geriatrics found that anticholinergic exposure to one, two, three, and four or more medications was associated with a 1.6, 2.1, 2.6, and 2.6 times, respectively, increased risk of a dementia/Alzheimer’s disease diagnosis compared to periods of no ACH exposure.[5]

The American Geriatrics Society recommends avoiding anticholinergic medications in older adults because they are more likely to experience unwanted side effects.[3] These side effects can include confusion, memory loss, and worsening mental function.[3]

The increased risk of dementia associated with anticholinergic use is a significant concern, particularly for older adults. Studies have shown that long-term use of these medications can increase the risk of developing dementia. For example, the JAMA Internal Medicine study found a 54% higher dementia risk for those taking anticholinergics for the equivalent of three years or more.[1] Another study in BMC Geriatrics found that anticholinergic exposure to one, two, three, and four or more medications was associated with a 1.6, 2.1, 2.6, and 2.6 times, respectively, increased risk of a dementia/Alzheimer’s disease diagnosis compared to periods of no ACH exposure.[5]


Authoritative Sources

  1. Common anticholinergic drugs like Benadryl linked to increased dementia risk. [Harvard Health Publishing]
  2. Anticholinergics. [Healthline]
  3. Anticholinergic exposure and its association with dementia/Alzheimer's disease and mortality in older adults. [BMC Geriatrics]

Answer Provided by iAsk.ai – Ask AI.

Sign up for free to save this answer and access it later

Sign up →

Web Results

Anticholinergic burden in older people
https//bpac.org.nz › 2024 › anticholinergic.aspx
Anticholinergic burden in older people
This group is at increased risk of acute adverse anticholinergic effects (e.g. dry mouth, blurred vision, urinary retention and drowsiness) as ...
Oxybutynin-associated Cognitive Impairment: Evidence ...
https//www.sciencedirect.com › science › article › pii › S0090429524000062
Oxybutynin-associated Cognitive Impairment: Evidence ...
It found an increased risk of incident dementia among patients receiving anticholinergics relative to those receiving β3-adrenergic receptor agonists (HR ...
Benadryl Dementia (Cognitive Decline & Alzheimer's Risk)
https//optoceutics.com › benadryl-dementia-relation-causes-brain-health-studies
Benadryl Dementia (Cognitive Decline & Alzheimer's Risk)
Elderly people consuming anticholinergics may worsen the risk of getting dementia as their brains may not be able to metabolize the medication.
Cumulative Use of Strong Anticholinergics and Incident ...
https//jamanetwork.com › journals › jamainternalmedicine › fullarticle › 2091745
Cumulative Use of Strong Anticholinergics and Incident ...
A well-known risk with anticholinergics is acute impairment in specific aspects of cognition (eg, working memory, attention, and psychomotor speed), which has ...
Oxybutynin-associated Cognitive Impairment: Evidence ...
https//www.goldjournal.net › article › S0090-4295(24)00006-2 › fulltext
Oxybutynin-associated Cognitive Impairment: Evidence ...
It found an increased risk of incident dementia among patients receiving anticholinergics relative to those receiving β3-adrenergic receptor ...
Increased risk of incident dementia following use ...
https//pmc.ncbi.nlm.nih.gov › articles › PMC7821204
Increased risk of incident dementia following use ...
Anticholinergic use for ≥3 months increased the risk of dementia on average by an estimated 46% versus nonuse. This relationship was consistent ...
Cumulative Use of Strong Anticholinergic Medications and ...
https//pmc.ncbi.nlm.nih.gov › articles › PMC4358759
Cumulative Use of Strong Anticholinergic Medications and ...
A well-known risk with anticholinergic medications is acute impairment in specific aspects of cognition (e.g., working memory, attention, psychomotor speed) ...